Pharmacology of the human CGRP1 receptor in Cos 7 cells

Peptides

Volumn 27, Issue 6, 2006, Pages 1367-1375

  Bailey, Richard J ^a   Hay, Debbie L ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

BIBN4096BS; Calcitonin receptor like receptor; CGRP; CGRP1 receptor; Receptor activity modifying protein

Indexed keywords

ADRENOMEDULLIN; AMYLIN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CYCLIC AMP; OLCEGEPANT; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; CALCIUM; PEPTIDE; PROCALCITONIN; PROTEIN PRECURSOR; RECOMBINANT PROTEIN; RNA;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENCY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; HUMAN; KINETICS; METABOLISM; RAT; SALMON;

ADRENOMEDULLIN; ANIMALS; CALCITONIN; CALCIUM; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; KINETICS; PEPTIDES; PROTEIN PRECURSORS; RATS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SALMON;

EID: 33747276441     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.11.014     Document Type: Article

References (34)

1. Aiyar N., Disa J., Zhaohui A., Dong X., Surya A., Pillarisetti K., et al. Molecular cloning and pharmacological characterization of bovine calcitonin receptor-like receptor from bovine aortic endothelial cells. Biochem Pharmacol 63 (2002) 1949-1959
2. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., et al. A versatile vector for gene and oligonucleotides transfer into cells in culture and in vivo: polyethyleneimine. Proc Natl Acad Sci USA 92 (1995) 7297-7301
3. Brain S.D., and Grant A.D. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84 (2004) 903-934
4. Chauhan M., Thota C.S., Kondapaka S., Wimalawansa S., and Yallampalli C. Evidence for the existence of a new receptor for CGRP, which is not CRLR. Peptides 24 (2003) 65-71
5. Choksi T., Hay D.L., Legon S., Poyner D.R., Hagner S., Bloom S.R., et al. Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and AM binding in cell lines. Br J Pharmacol 136 (2002) 784-792
6. Conner A.C., Hay D.L., Simms J., Howitt S.G., Schindler M., Smith D.M., et al. A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: implications for family B G-protein coupled receptors. Mol Pharmacol 67 (2005) 20-31
7. Dennis T., Fournier A., Cadieux A., Pomerleau F., Jolicoeur F.B., and Quirion R. hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther 254 (1990) 123-128
8. Dennis T., Fournier A., St Pierre S., and Quirion R. Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther 251 (1989) 718-725
9. Doods H., Hallermayer G., Wu D., Entzeroth M., Rudolf K., Engel W., et al. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 129 (2000) 420-423
10. Dumont Y., Fournier A., St-Pierre S., and Quirion R. A potent and selective CGRP2 agonist [Cys(Et)2,7]hCGRP alpha: comparison in prototypical CGRP1 and CGRP2 in vitro bioassays. Can J Physiol Pharmacol 75 (1997) 671-676
11. Esfandyari T., Macnaughton W.K., Quirion R., St Pierre S., Junien J.L., and Sharkey K.A. A novel receptor for calcitonin gene-related peptide (CGRP) mediates secretion in the rat colon: implications for secretory function in colitis. FASEB J 14 (2000) 1439-1446
12. Hay D.L., Christopoulos G., Christopoulos A., Poyner D.R., and Sexton P.M. Pharmacological discrimination of calcitonin receptor-receptor activity modifying protein complexes. Mol Pharmacol 67 (2005) 1655-1665
13. Hay D.L., Conner A.C., Howitt S.G., Takhshid M.A., Simms J., Mahmoud K., et al. The pharmacology of CGRP responsive receptors in cultured and transfected cells. Peptides 25 (2004) 2019-2026
14. Hay D.L., Howitt S.G., Conner A.C., Doods H., Schindler M., and Poyner D.R. A comparison of the actions of BIBN4096BS and CGRP(8-37) on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6 Col 29 and Rat 2 cells. Br J Pharmacol 137 (2002) 80-86
15. Hay D.L., Howitt S.G., Conner A.C., Schindler M., Smith D.M., and Poyner D.R. CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52 CGRP8-37 and BIBN4096BS. Br J Pharmacol 140 (2003) 477-486
16. Hirt D., and Bernard G.W. CGRP-beta unlike CGRP-alpha has no osteogenic stimulatory effect in vitro. Peptides 18 (1997) 1461-1463
17. Juaneda C., Dumont Y., and Quirion R. The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol Sci 21 (2000) 432-438
18. Kawase T, Okuda K, Burns DM. Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that differentially respond to [Cys(Acm)2,7]-CGRP and CGRP8-37. Am J Physiol Cell Physiol 2005 [published online Jun 15].
19. Kuwasako K., Cao Y., Nagoshi Y., Tsuruda T., Kitamura K., and Eto T. Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity modifying proteins. Mol Pharmacol 65 (2004) 207-213
20. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393 (1998) 333-339
21. Mallee J.J., Salvatore C.A., LeBourdelles B., Oliver K.R., Longmore J., Koblan S., et al. Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J Biol Chem 277 (2002) 14294-14298
22. 1 receptors in SK-N-MC cells. Biochem Pharmacol 69 (2005) 1235-1240
23. Nuki C., Kawasaki H., Kitamura K., Tagenaga M., Kangawa K., Eto T., et al. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun 196 (1993) 245-251
24. Olesen J., Diener H.C., Husstedt I.W., Goadsby P.J., Hall D., Meier U., et al. BIBN 4096 BS clinical proof of concept study group calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350 (2004) 1104-1110
25. Poyner D.R., Andrew D.P., Brown D., Bose C., and Hanley M.R. Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat L6 myocytes. Br J Pharmacol 105 (1992) 441-447
26. Poyner D.R., Sexton P.M., Marshall I., Smith D.M., Quirion R., Born W., et al. International union of pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54 (2002) 233-246
27. Poyner D.R., Taylor G.M., Tomlinson A.E., Richardson A.G., and Smith D.M. Characterization of receptors for calcitonin gene-related peptide and adrenomedullin on the guinea-pig vas deferens. Br J Pharmacol 126 (1999) 1276-1282
28. Rorabaugh B.R., Scofield M.A., Smith D.D., Jeffries W.B., and Abel P.W. Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction. J Pharmacol Exp Ther 299 (2001) 1086-1094
29. Schindler M., and Doods H.N. Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand [(3)H]BIBN4096BS. Eur J Pharmacol 442 (2002) 187-193
30. Verheggen R., Bumann K., and Kaumann A.J. BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37). Br J Pharmacol 136 (2002) 120-126
31. Van Rossum D., Uwe-Karsten H., and Quirion R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev 21 (1994) 649-678
32. Waugh D.J., Bockman C.S., Smith D.D., and Abel P.W. Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors. J Pharmacol Exp Ther 289 (1999) 1419-1426
33. Wu D., Eberlein W., Rudolf K., Engel W., Hallermayer G., and Doods H. Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2, 7)]hCGRP-preferring receptor. Eur J Pharmacol 21 400 (2000) 313-319
34. Zimmermann U., Fischer J.A., and Muff R. Adrenomedullin and calcitonin gene-related peptide interact with the same receptor in cultured human neuroblastoma SK-N-MC cells. Peptides 16 (1995) 421-424